Page last updated: 2024-09-04

moxifloxacin and Antibiotic-Associated Colitis

moxifloxacin has been researched along with Antibiotic-Associated Colitis in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	14 (58.33)	29.6817
2010's	10 (41.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP	1
Adams, DA; Donskey, CJ; Riggs, MM	1
Karlowsky, JA; Laing, NM; Zhanel, GG	1
Przybylski, DJ; Reeves, DJ	1
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L	1
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C	1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T	1
Barbanti, F; Spigaglia, P	1
Freeman, J; Pilling, S; Vernon, J; Wilcox, MH	1
Fang, H; Huang, H; Nord, CE; Weintraub, A	1
Du, JK; Gallagher, JC; Rose, C	1
Carman, RJ; Genheimer, CW; Hiltonsmith, MF; Lyerly, DM; Park, M; Rafii, F	1
Ackermann, G; Christner, M; Ilchmann, C; Rohde, H; Speicher, A; Zaiss, NH	1
Barbanti, F; Mastrantonio, P; Spigaglia, P	1
Akerlund, T; Alefjord, I; Dohnhammar, U; Noren, T; Struwe, J; Tegmark-Wisell, K	1
López-Causapé, C; Mena, A; Oliver, A; Pérez, JL; Riera, E; Weber, I	1
Barbut, F; Burghoffer, B; Dridi, L; Petit, JC; Tankovic, J	1
Ackermann, G; Cohen, SH; Degner, A; Rodloff, AC; Silva, J	1
López, R; Ortiz-de-Saracho, J; Pantoja, L; Romero, MJ	1
Ackermann, G; Cohen, SH; Henderson, JP; Rodloff, AC; Schaumann, R; Silva, J; Tang-Feldman, YJ	1
Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H	1
Dhalla, IA; Juurlink, DN; Kopp, A; Mamdani, MM; Rochon, PA; Simor, AE	1
Biller, P; Brennan, M; Killgore, G; Lind, L; McDonald, LC; Shank, B; Thompson, A; Tkatch, L	1
Akerlund, T; Burman, LG; Norén, T; Persson, I; Svenungsson, B; Unemo, M; Wullt, M	1

Other Studies

24 other study(ies) available for moxifloxacin and Antibiotic-Associated Colitis

Article	Year
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States	2007
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Toxins; Cecum; Clostridioides difficile; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Mice; Microbial Sensitivity Tests	2007
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests	2008
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies	2017
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin	2018
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin	2015
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks. Emerging microbes & infections, 2016, May-11, Volume: 5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin	2016
Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type. Anaerobe, 2016, Volume: 42 Topics: Anti-Bacterial Agents; Antibiosis; Bacterial Adhesion; Bacterial Toxins; Caco-2 Cells; Clindamycin; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Hospitals; Humans; Italy; Moxifloxacin; Ribotyping; Rifampin; Virulence	2016
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polymerase Chain Reaction; Pyrrolidines; Quinolones; Ribotyping	2017
Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Scandinavian journal of infectious diseases, 2009, Volume: 41, Issue:2 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Community-Acquired Infections; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Ribotyping; Sweden	2009
Severe pseudomembranous colitis after moxifloxacin use: a case series. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fatal Outcome; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines	2009
Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe, 2009, Volume: 15, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Diarrhea; Disease Outbreaks; DNA Gyrase; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genetic Variation; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Ribotyping	2009
Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:12 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Typing Techniques; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Germany; Hospitals, University; Humans; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Prevalence; Quinolines; Ribotyping	2010
Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Canada; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Epidemics; Erythromycin; Europe; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Phylogeny; Polymerase Chain Reaction; Quinolines; Ribotyping; Sequence Analysis, DNA; Virulence	2011
Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2011, Mar-10, Volume: 16, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Cluster Analysis; DNA Gyrase; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Geography; Humans; Laboratories; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Polymerase Chain Reaction; Population Surveillance; Prevalence; Quinolines; Ribotyping; Sweden	2011
In vivo selection of moxifloxacin-resistant Clostridium difficile. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; DNA Gyrase; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Isoenzymes; Male; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Sequence Analysis, DNA	2012
gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:11 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; DNA Gyrase; DNA, Fungal; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Reverse Transcriptase Polymerase Chain Reaction	2002
Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Lincosamides; Macrolides; Moxifloxacin; Prevalence; Quinolines; Streptogramin B	2003
Moxifloxacin-induced Clostridium difficile diarrhea. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3 Topics: Adult; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines	2003
Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Moxifloxacin; Polymerase Chain Reaction; Quinolines	2003
Moxifloxacin prophylaxis in neutropenic patients. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:4 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines	2006
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease? Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9 Topics: Aged; Aged, 80 and over; Aza Compounds; Case-Control Studies; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines	2006
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infection control and hospital epidemiology, 2007, Volume: 28, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Risk Factors	2007
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. Journal of clinical microbiology, 2008, Volume: 46, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Disease Outbreaks; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Repressor Proteins; Ribotyping; Spores, Bacterial; Virulence	2008